Osteopontin Production Crucial Role in Lupus Pathogenesis Via with Cell

Total Page:16

File Type:pdf, Size:1020Kb

Osteopontin Production Crucial Role in Lupus Pathogenesis Via with Cell A CD153+CD4+ T Follicular Cell Population with Cell-Senescence Features Plays a Crucial Role in Lupus Pathogenesis via Osteopontin Production This information is current as of September 30, 2021. Suhail Tahir, Yuji Fukushima, Keiko Sakamoto, Kyosuke Sato, Harumi Fujita, Joe Inoue, Toshimitsu Uede, Yoko Hamazaki, Masakazu Hattori and Nagahiro Minato J Immunol 2015; 194:5725-5735; Prepublished online 13 May 2015; Downloaded from doi: 10.4049/jimmunol.1500319 http://www.jimmunol.org/content/194/12/5725 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/05/13/jimmunol.150031 Material 9.DCSupplemental References This article cites 41 articles, 8 of which you can access for free at: http://www.jimmunol.org/content/194/12/5725.full#ref-list-1 Why The JI? Submit online. by guest on September 30, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology A CD153+CD4+ T Follicular Cell Population with Cell-Senescence Features Plays a Crucial Role in Lupus Pathogenesis via Osteopontin Production Suhail Tahir,* Yuji Fukushima,† Keiko Sakamoto,* Kyosuke Sato,* Harumi Fujita,* Joe Inoue,* Toshimitsu Uede,‡ Yoko Hamazaki,* Masakazu Hattori,† and Nagahiro Minato* Immune aging results in diminished adaptive immunity and increased risk for autoimmunity. We previously reported a unique PD- 1+ CD44highCD4+ T cell population that increases with age in normal mice. In this study, we indicate that the age-dependent PD-1+ CD44highCD4+ T cells develop as unique T follicular (TF) cells in a B cell–dependent manner and consist of two subpopulations, as follows: CD153+ cells preferentially secreting abundant osteopontin on TCR stimulation and CD1532 cells that are apparently Downloaded from TCR anergic. These unique TF cells with essentially similar features increase much earlier and are accumulated in the sponta- neous germinal centers (GCs) in lupus-prone female BWF1 (f-BWF1) mice. These TF cells showed characteristic cell-senescence features and developed in association with extensive CD4+ T cell proliferation in vivo, suggesting replicative senescence. Although the CD153+ TF cells were defective in proliferation capacity, they were quite stable and specifically responded to self GC-B cells to secret abundant osteopontin, which inhibited B cell receptor–induced GC-B cell apoptosis in f-BWF1 mice. Transfer of CD153+ PD-1+ CD4+ T cells promoted the growth of spontaneous GCs, whereas administration of anti-osteopontin Ab suppressed GC http://www.jimmunol.org/ enlargement and anti-nuclear Ab production and ameliorated clinical lupus nephritis of f-BWF1 mice. Current results suggest that senescent CD153+ TF cells generated as a consequence of extensive endogenous CD4+ T cell proliferation play an essential, if not sufficient, role in lupus pathogenesis in lupus-prone genetic background and may also contribute to an increased autoimmu- nity risk with age. The Journal of Immunology, 2015, 194: 5725–5735. erminal centers (GCs) are unique niches in secondary may be recruited to GCs, including TF helper (TFH) cells, regu- lymphoid tissues in which a specific Ab response occurs latory T cells, and NKT cells (7). G after Ag immunization (1). In GCs, Ag-specific B cells GC reactions may occur spontaneously in various autoimmune by guest on September 30, 2021 undergo a series of dynamic processes, including robust prolifer- diseases, including lupus (8, 9). Lupus disease, which preferen- ation, somatic hypermutation, and class-switch recombination of tially affects young females in humans, is a multifactorial disease BCR genes, affinity maturation, and differentiation into memory affecting various organs, most commonly glomerulonephritis. A or plasma cells (2). The initiation of GC reaction requires Ag- hallmark of the disease is production of autoantibodies against specific T cells (3). After Ag immunization, some of these T cells a diverse spectrum of self-Ags, including nuclear components (10, migrate into the follicular B cell region to regulate specific GC 11). Among several immune disorders in lupus is a defective reactions and are called T follicular (TF) cells (4–6). Accumu- checkpoint of B cell self-tolerance (12). Although potentially self- lating evidence indicates that functionally distinct types of T cells reactive B cells are normally excluded from GCs, they are in- cluded in GCs in the lupus-prone genetic background, leading to overt autoantibody production (13, 14). Recent studies highlight *Department of Immunology and Cell Biology, Graduate School of Medicine, Kyoto an important role of TF cells in the spontaneous GC reactions of University, Kyoto 606-8501, Japan; †Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, lupus disease (15–17). However, it remains elusive how such spon- Kyoto 606-8501, Japan; and ‡Division of Molecular Immunology, Institute for Ge- taneous GC reactions develop and are regulated. netic Medicine, Hokkaido University, Sapporo 060-0815, Japan We previously identified a PD-1+ CD44highCD62LlowCD4+ Received for publication February 10, 2015. Accepted for publication April 17, 2015. T cell population that steadily increases age dependently in normal This work was supported by a Grant-in-Aid for Scientific Research on Innovative B6 mice (18). The CD4+ T cell population, termed senescence- Areas from the Japan Society for the Promotion of Science; Special Coordination associated T (SA-T) cells, shows unique genetic signature and Funds for Promoting Science and Technology from the Japanese Government; the “Formation of Innovation Center for Fusion of Advanced Technologies” program of functional features, including attenuated TCR-mediated prolifer- Astellas Pharma, Inc.; the Uehara Memorial Foundation; and Ono Pharmaceutical ation and highly biased secretion of osteopontin (OPN), suggest- Co., Ltd. ing their contribution to reduced acquired immunity and increased Address correspondence and reprint requests to Prof. Nagahiro Minato, Department inflammatory trait in senescence (18). Most recently, it was re- of Immunology and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan. E-mail address: [email protected] ported that unique TF cells with a similar genetic signature to SA- The online version of this article contains supplemental material. T cells were increased in B6.Sle1b congenic mice (19), which Abbreviations used in this article: ANA, anti-nuclear Ab; EGFP, enhanced GFP; develop anti-nuclear Abs (ANAs) but no clinical disease (11). f-BWF1, female BWF1; GC, germinal center; miR, microRNA; OPN, osteopontin; Although Slamf6 receptor coded in a Sle1b gene cluster was in- PNA, peanut agglutinin; SA-T, senescence-associated T; TF, T follicular; TFH, TF dicated to play a crucial role in the increase of TF cells and ANA helper. production (19), the origin and relation of them with SA-T cells Copyright Ó 2015 by The American Association of Immunologists, Inc. 0022-1767/15/$25.00 remain unknown. www.jimmunol.org/cgi/doi/10.4049/jimmunol.1500319 5726 SENESCENT CD153+ TF CELLS IN LUPUS PATHOGENESIS In the current study, we indicate that SA-T cells develop as a unique Laser-capture microdissection TF cell population in normal B6 mice with age and much prematurely Cryostat sections were affixed to frame membrane slides for the ArcturusXT in bone fide lupus-prone female BWF1 (f-BWF1) mice, in association LMD system (Life Technologies), fixed in acetone, and stained with bio- with spontaneous GC reactions. The SA-T cells in both aged B6 mice tinylated PNA and HistoGene immunofluorescence staining kit. After XT andf-BWF1micearedevelopedinassociation with extensive en- dehydration, the regions of interest were dissected on an Arcturus sys- dogenous CD4+ T cell proliferation in vivo and show characteristic tem (Life Technologies). cell-senescence features. We demonstrate that a minor cell population Quantitative PCR expressing CD153 in the SA-T cells plays a crucial role in sponta- Quantitative PCR was performed with SYBR Green I Master mix (Roche) on neous GC reactions and development of clinical lupus nephritis. a LightCycler 480 (Roche). Cyclophilin and U6 RNA were used as internal controls for mRNA and microRNAs (miRs), respectively. Primer sequences Materials and Methods for genes and miR are as follows: Tnfsf8,59-GAGGATCTCTTCTG- TACCCTGAAA-39 and 59-TTGGTATTGTTGAGATGCTTTGA-39; Spp1, Mice 59-CCCGGTGAAAGTGACTGATT-39 and 59-TTCTTCAGAGGACACA- New Zealand White, New Zealand Black, New Zealand Black 3 New GCATTC-39; Il1r2,59-CCCATCCCTGTGATCATTTC-39 and 59-GCAC- GGGACTATCAGTCTTGA-39; Ccl3,59-TCTGTCACCTGCTCAACA- Zealand White F1 (BWF1), and C57BL/6 (B6) mice were purchased from Japan SLC, and mMT mice were provided by M. Reth
Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Age- and Gender-Specific Modulation of Serum Osteopontin and Interferon-Α by Osteopontin Genotype in Systemic Lupus Er
    Genes and Immunity (2009) 10, 487–494 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Age- and gender-specific modulation of serum osteopontin and interferon-a by osteopontin genotype in systemic lupus erythematosus SN Kariuki1, JG Moore1, KA Kirou2,MKCrow2, TO Utset1 and TB Niewold1 1Section of Rheumatology, University of Chicago, Chicago, IL, USA and 2Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY, USA Osteopontin (OPN) is a multifunctional cytokine involved in long bone remodeling and immune system signaling. Additionally, OPN is critical for interferon-a (IFN-a) production in murine plasmacytoid dendritic cells. We have previously shown that IFN-a is a heritable risk factor for systemic lupus erythematosus (SLE). Genetic variants of OPN have been associated with SLE susceptibility, and one study suggests that this association is particular to men. In this study, the 3 0 UTR SLE-risk variant of OPN (rs9138C) was associated with higher serum OPN and IFN-a in men (P ¼ 0.0062 and P ¼ 0.0087, respectively). In women, the association between rs9138 C and higher serum OPN and IFN-a was restricted to younger subjects, and risk allele carriers showed a strong age-related genetic effect of rs9138 genotype on both serum OPN and IFN-a (Po0.0001). In African- American subjects, the 5 0 region single nucleotide polymorphisms, rs11730582 and rs28357094, were associated with anti- RNP antibodies (odds ratio (OR) ¼ 2.9, P ¼ 0.0038 and OR ¼ 3.9, P ¼ 0.021, respectively). Thus, we demonstrate two distinct genetic influences of OPN on serum protein traits in SLE patients, which correspond to previously reported SLE-risk variants.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) Balancing effector lymphocyte formation via CD27-CD70 interactions Arens, R. Publication date 2003 Link to publication Citation for published version (APA): Arens, R. (2003). Balancing effector lymphocyte formation via CD27-CD70 interactions. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:27 Sep 2021 Chapter 3 Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNy-mediated B cell depletion Ramon Arens*, Kiki Tesselaar*, Paul A. Baars, Gijs M.W. van Schijndel, Jenny Hendriks, Steven T. Pals, Paul Krimpenfort, Jannie Borst, Marinus H.J. van Oers, and René A.W. van Lier 'These authors contributed equally to this work Immunity 15, 801-812 (2001) Chapter 3 Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNy-mediated B cell depletion Ramon Arens123#, Kiki Tesselaar23", Paul A.
    [Show full text]
  • Dendritic Cell Expression of CD70 in Vivo Potent Cellular Immunity By
    Combined TLR/CD40 Stimulation Mediates Potent Cellular Immunity by Regulating Dendritic Cell Expression of CD70 In Vivo This information is current as Phillip J. Sanchez, Jennifer A. McWilliams, Catherine of September 25, 2021. Haluszczak, Hideo Yagita and Ross M. Kedl J Immunol 2007; 178:1564-1572; ; doi: 10.4049/jimmunol.178.3.1564 http://www.jimmunol.org/content/178/3/1564 Downloaded from References This article cites 57 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/178/3/1564.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Combined TLR/CD40 Stimulation Mediates Potent Cellular Immunity by Regulating Dendritic Cell Expression of CD70 In Vivo1 Phillip J. Sanchez,* Jennifer A. McWilliams,* Catherine Haluszczak,* Hideo Yagita,† and Ross M. Kedl2* We previously showed that immunization with a combination of TLR and CD40 agonists (combined TLR/CD40 agonist immu- nization) resulted in an expansion of Ag-specific CD8 T cells exponentially greater than the expansion observed to immunization with either agonist alone.
    [Show full text]
  • Gene Symbol Category ACAN ECM ADAM10 ECM Remodeling-Related ADAM11 ECM Remodeling-Related ADAM12 ECM Remodeling-Related ADAM15 E
    Supplementary Material (ESI) for Integrative Biology This journal is (c) The Royal Society of Chemistry 2010 Gene symbol Category ACAN ECM ADAM10 ECM remodeling-related ADAM11 ECM remodeling-related ADAM12 ECM remodeling-related ADAM15 ECM remodeling-related ADAM17 ECM remodeling-related ADAM18 ECM remodeling-related ADAM19 ECM remodeling-related ADAM2 ECM remodeling-related ADAM20 ECM remodeling-related ADAM21 ECM remodeling-related ADAM22 ECM remodeling-related ADAM23 ECM remodeling-related ADAM28 ECM remodeling-related ADAM29 ECM remodeling-related ADAM3 ECM remodeling-related ADAM30 ECM remodeling-related ADAM5 ECM remodeling-related ADAM7 ECM remodeling-related ADAM8 ECM remodeling-related ADAM9 ECM remodeling-related ADAMTS1 ECM remodeling-related ADAMTS10 ECM remodeling-related ADAMTS12 ECM remodeling-related ADAMTS13 ECM remodeling-related ADAMTS14 ECM remodeling-related ADAMTS15 ECM remodeling-related ADAMTS16 ECM remodeling-related ADAMTS17 ECM remodeling-related ADAMTS18 ECM remodeling-related ADAMTS19 ECM remodeling-related ADAMTS2 ECM remodeling-related ADAMTS20 ECM remodeling-related ADAMTS3 ECM remodeling-related ADAMTS4 ECM remodeling-related ADAMTS5 ECM remodeling-related ADAMTS6 ECM remodeling-related ADAMTS7 ECM remodeling-related ADAMTS8 ECM remodeling-related ADAMTS9 ECM remodeling-related ADAMTSL1 ECM remodeling-related ADAMTSL2 ECM remodeling-related ADAMTSL3 ECM remodeling-related ADAMTSL4 ECM remodeling-related ADAMTSL5 ECM remodeling-related AGRIN ECM ALCAM Cell-cell adhesion ANGPT1 Soluble factors and receptors
    [Show full text]
  • Belongs to the TNF Family a New Class of Reverse Signaling
    A New Class of Reverse Signaling Costimulators Belongs to the TNF Family Mingyi Sun and Pamela J. Fink This information is current as J Immunol 2007; 179:4307-4312; ; of September 27, 2021. doi: 10.4049/jimmunol.179.7.4307 http://www.jimmunol.org/content/179/7/4307 References This article cites 85 articles, 38 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/179/7/4307.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on September 27, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. THE JOURNAL OF IMMUNOLOGY BRIEF REVIEWS A New Class of Reverse Signaling Costimulators Belongs to the TNF Family Mingyi Sun and Pamela J. Fink1 Recent evidence shows that many molecules of the TNF still remains unclear (7). The N-terminal cytoplasmic domains family serve as counter-receptors, inducing costimulation of most TNF family members are conserved across species but through reverse signals in addition to delivering signals not between family members, suggesting that the intracellular through their respective TNF receptors.
    [Show full text]
  • CD95 Ligand - Death Factor and Costimulatory Molecule?
    Cell Death and Differentiation (2003) 10, 1215–1225 & 2003 Nature Publishing Group All rights reserved 1350-9047/03 $25.00 www.nature.com/cdd Review CD95 ligand - death factor and costimulatory molecule? O Janssen*,1, J Qian1, A Linkermann1 and D Kabelitz1 Tissue and Cellular Expression of CD95L 1 Institute for Immunology, Medical Center Schleswig-Holstein, Campus Kiel, Michaelisstrasse 5, D-24105 Kiel, Germany The CD95 ligand (CD95L, Apo-1L, FasL, CD178) is a 281- * Corresponding author: O Janssen. Tel: þ 49-431-5973377; Fax: þ 49-431- amino-acid-containing type II transmembrane protein of the 5973335; E-mail: [email protected] TNF family of death factors (Figure 1).1 Its death-inducing function is best documented in the context of activation- Received 24.4.03; revised 12.6.03; accepted 20.6.03; published online 1 August 2003 induced cell death (AICD) in T cells.2 CD95L is expressed as a Edited by T Ferguson death factor in cytotoxic T lymphocytes (CTL) to kill virally infected or transformed target cells and in natural killer (NK) cells, where it is upregulated by CD16 engagement and 3 Abstract cytokines including IL-2 and IL-12. Similarly, high levels of intracellular CD95L have been detected in monocytic cells The CD95 ligand is involved as a death factor in the with an inducible release upon activation.4 Under physiologi- regulation of activation-induced cell death, establishment cal conditions, CD95L is implicated in the control of erythroid of immune privilege and tumor cell survival. In addition, differentiation,5 angiogenesis in the eye6 and skin home- 7 CD95L may serve as a costimulatory molecule for T-cell ostasis.
    [Show full text]
  • Immunosenescence: a Key Player in Cancer Development Jingyao Lian1,2†, Ying Yue1,2,3†, Weina Yu1,2† and Yi Zhang1,2*
    Lian et al. J Hematol Oncol (2020) 13:151 https://doi.org/10.1186/s13045-020-00986-z REVIEW Open Access Immunosenescence: a key player in cancer development Jingyao Lian1,2†, Ying Yue1,2,3†, Weina Yu1,2† and Yi Zhang1,2* Abstract Immunosenescence is a process of immune dysfunction that occurs with age and includes remodeling of lymphoid organs, leading to changes in the immune function of the elderly, which is closely related to the development of infections, autoimmune diseases, and malignant tumors. T cell–output decline is an important feature of immunose- nescence as well as the production of senescence-associated secretory phenotype, increased glycolysis, and reactive oxygen species. Senescent T cells exhibit abnormal phenotypes, including downregulation of CD27, CD28, and upreg- ulation of CD57, killer cell lectin-like receptor subfamily G, Tim-3, Tight, and cytotoxic T-lymphocyte-associated protein 4, which are tightly related to malignant tumors. The role of immunosenescence in tumors is sophisticated: the many factors involved include cAMP, glucose competition, and oncogenic stress in the tumor microenvironment, which can induce the senescence of T cells, macrophages, natural killer cells, and dendritic cells. Accordingly, these senescent immune cells could also afect tumor progression. In addition, the efect of immunosenescence on the response to immune checkpoint blocking antibody therapy so far is ambiguous due to the low participation of elderly cancer patients in clinical trials. Furthermore, many other senescence-related interventions could be possible with genetic and pharmacological methods, including mTOR inhibition, interleukin-7 recombination, and NAD + activation. Overall, this review aims to highlight the characteristics of immunosenescence and its impact on malignant tumors and immunotherapy, especially the future directions of tumor treatment through senescence-focused strategies.
    [Show full text]
  • Intracellular Cleavage of Osteopontin by Caspase-8 Modulates Hypoxia/Reoxygenation Cell Death Through P53
    Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53 Hyo-Jin Kima, Ho-June Leea, Joon-Il Junb, Yumin Oha, Seon-Guk Choia, Hyunjoo Kima, Chul-Woong Chungc, In-Ki Kimd, Il-Sun Parke, Han-Jung Chaef, Hyung-Ryong Kimg, and Yong-Keun Junga,1 aCreative Research Initiative Acceleration Research, School of Biological Science/Bio-Max Institute, Seoul National University, Seoul 151–747, Korea; bDepartment of Life Science, Gwangju Institute of Science and Technology, Gwangju 500–712, Korea; cLG Life Science Research Park, Daejon 305–389, Korea; dOntario Cancer Institute, Toronto, Ontario M5G 2M9, Canada; eDepartment of Bio-Materials Engineering and Molecular Medicine, School of Medicine, Chosun University, Gwangju 501–759, Korea; fSchool of Medicine, Chonbuk National University, Chonbuk 560–180, Korea, and gDepartment of Dental Pharmacology, School of Dentistry, Wonkwang University, Chonbuk 570–749, Korea Edited by Harvey Cantor, Dana-Farber Cancer Institute, Boston, MA, and approved July 20, 2009 (received for review April 3, 2009) Osteopontin (OPN) is highly expressed in cancer patients and plays after massive generation of reactive oxygen species (ROS) and important roles in many stages of tumor progression, such as anti- caspases activation. Several caspases including caspases-8, -9, and -3 apoptosis, proliferation, and metastasis. From functional screening of were reported to be activated during reoxygenation, which is human cDNA library, we isolated OPN as a caspase-8 substrate that required for Hyp/RO-induced cell death (11, 12). Among these regulates cell death during hypoxia/reoxygenation (Hyp/RO). In vitro caspases, caspase-8 is a well known receptor-proximal caspase.
    [Show full text]
  • 1208.Full-Text.Pdf
    Published OnlineFirst June 19, 2019; DOI: 10.1158/2159-8290.CD-18-1454 RESEARCH ARTICLE Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Effi cacy in Triple-Negative Breast Cancer Jaclyn Sceneay 1 , 2 , Gregory J. Goreczny 1 , 2 , Kristin Wilson 1 , Sara Morrow 1 , Molly J. DeCristo 1 , 2 , Jessalyn M. Ubellacker1 , 2 , Yuanbo Qin 1 , 2 , Tyler Laszewski 1 , Daniel G. Stover 3 , Victor Barrera 4 , John N. Hutchinson 4 , Rachel A. Freedman 5 , 6 , Elizabeth A. Mittendorf 6 , 7 , and Sandra S. McAllister 1 , 2 , 8 , 9 ABSTRACT Immune checkpoint blockade (ICB) therapy, which targets T cell–inhibitory recep- tors, has revolutionized cancer treatment. Among the breast cancer subtypes, evaluation of ICB has been of greatest interest in triple-negative breast cancer (TNBC) due to its immunogenicity, as evidenced by the presence of tumor-infi ltrating lymphocytes and elevated PD-L1 expression relative to other subtypes. TNBC incidence is equally distributed across the age spectrum, affecting 10% to 15% of women in all age groups. Here we report that increased immune dysfunction with age limits ICB effi cacy in aged TNBC-bearing mice. The tumor microenvironment in both aged mice and patients with TNBC shows decreased IFN signaling and antigen presentation, suggesting failed innate immune activation with age. Triggering innate immune priming with a STING agonist restored response to ICB in aged mice. Our data implicate age-related immune dysfunction as a mechanism of ICB resistance in mice and suggest potential prognostic utility of assessing IFN-related genes in patients with TNBC receiving ICB therapy.
    [Show full text]
  • Viewed by the Institutional Lab- M2mws Were Counted, and 1.03106 Viable Cells Were Suspended in Oratory Animal Care and Use Committee of Nagoya City University
    BASIC RESEARCH www.jasn.org Colony-Stimulating Factor-1 Signaling Suppresses Renal Crystal Formation † Kazumi Taguchi,* Atsushi Okada,* Hiroshi Kitamura, Takahiro Yasui,* Taku Naiki,* Shuzo Hamamoto,* Ryosuke Ando,* Kentaro Mizuno,* Noriyasu Kawai,* Keiichi Tozawa,* ‡ ‡ † Kenichi Asano, Masato Tanaka, Ichiro Miyoshi, and Kenjiro Kohri* Departments of *Nephro-urology, and †Comparative and Experimental Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; and ‡Laboratory of Immune Regulation, School of Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan ABSTRACT We recently reported evidence suggesting that migrating macrophages (Mws) eliminate renal crystals in hyperoxaluric mice. Mwscanbeinflammatory (M1) or anti-inflammatory (M2), and colony-stimulating factor-1 (CSF-1) mediates polarization to the M2Mw phenotype. M2Mws promote renal tissue repair and regeneration, but it is not clear whether these cells are involved in suppressing renal crystal formation. We investigated the role of M2Mws in renal crystal formation during hyperoxaluria using CSF-1–deficient mice, which lack M2Mws. Compared with wild-type mice, CSF-1–deficient mice had significantly higher amounts of renal calcium oxalate crystal deposition. Treatment with recombinant human CSF-1 increased the expression of M2-related genes and markedly decreased the number of renal crystals in both CSF-1– deficient and wild-type mice. Flow cytometry of sorted renal Mws showed that CSF-1 deficiency resulted in a smaller population of CD11b+F4/80+CD163+CD206hi cells, which represent M2-like Mws. Additionally, transfusion of M2Mws into CSF-1–deficient mice suppressed renal crystal deposition. In vitro phagocytosis assays with calcium oxalate monohydrate crystals showed a higher rate of crystal phagocytosis by M2- polarized Mws than M1-polarized Mws or renal tubular cells.
    [Show full text]
  • Snapshot: Cytokines III Cristina M
    SnapShot: Cytokines III Cristina M. Tato and Daniel J. Cua Schering-Plough Biopharma (Formerly DNAX Research), Palo Alto, CA 94304, USA Cytokine Receptor Source Targets Major Function Disease Association TNFα Murine: Macrophages, Neutrophils, Inflammatory; ↓ = disregulated fever; increased TNFR,p55; TNFR,p75 monocytes, T cells, macrophages, promotes activation susceptibility to bacterial infection; others monocytes, and production of enhanced resistance to LPS-induced septic Human: endothelial cells acute-phase proteins shock TNFR,p60; TNFR,p80 ↑ = exacerbation of arthritis and colitis LTα Murine: T cells, B cells Many cell types Promotes activation ↓ = defective response to bacterial TNFR,p55; TNFR,p75 and cytotoxicity; pathogens; absence of peripheral lymph development of lymph nodes and Peyer’s patches Human: nodes and Peyer’s TNFR,p60; TNFR,p80 patches LTβ LTβR T cells, B cells Myeloid cells, other Peripheral lymph ↓ = increased susceptibility to bacterial cell types node development; infection; absence of lymph nodes and proinflammatory Peyer’s patches ↑ = ectopic lymph node formation LIGHTa LTβR, DcR3, HVEM Activated T cells, B cells, NK cells, Costimulatory; ↓ = defective CD8 T cell costimulation monocytes, DCs DCs, other tissue promotes CTL activity TWEAK Fn14 Monocytes, Tissue progenitors, Proinflammatory; macrophages, epithelial, promotes cell growth endothelial endothelial for tissue repair and remodeling APRIL TACI, BAFF-R, BCMA Macrophages, DCs B cell subsets Promotes T cell- ↓ = impaired class switching to IgA independent
    [Show full text]